SCN1A-UP! at the end – Gene therapy approaches
In this video, Dr Gaia Colasante summarizes the strategies and......
Activity Events News Specialist AreaIn this video, Dr Gaia Colasante summarizes the strategies and......
Activity Events News Specialist AreaIn the video above, Dr Massimo Mantegazza, the coordinator of......
Activity Events News Specialist AreaThe European Epilepsy Congress has shown significant growth in recent......
Activity Events NewsThe project SCN1A-UP!, coordinated by Dr Massimo Mantegazza and funded......
Activity Events News Specialist AreaThe development of more effective support systems and an enhanced......
Activity News Specialist AreaSUDEP is that kind of word you don’t want to......
Activity Events NewsAlmost all discussions around Dravet Syndrome are uncomfortable but necessary.......
Events NewsThe Dravet Syndrome European Federation is happy to announce the appointment of Luis Miguel Aras as the new Chief Scientific Officer....
News Specialist AreaSCN1A-UP! has been selected among the projects to be funded by the European Joint Programme on Rare Diseases...
News Specialist AreaThis year’s Dravet Awareness banner has a record number of patient organizations and is more international than ever: 28 patient organizations from around the g...
Events NewsThe Committee for Orphan Medicinal Products (COMP) within the European Medicines Agency (EMA) has recently reviewed positively the application for orphan design...
News Specialist AreaA new publication coming from Poland offers detailed information about Dravet Syndrome population. The survey was conducted on 55 caregivers and considers diffe...
News Specialist AreaProud to receive new members - and hopefully also some unicorn power! Dravet Syndrome Ireland, founded only in 2020, has very recently joined Dravet Syndrome Eu...
News Specialist AreaDSEF representatives and Zogenix team have met recently and discussed about the possibility to extend the availability of the drug to more patients. Thus, the f...
News Specialist AreaThe Scientific Advisory Board of DSEF has formulated their latest recommendations on the COVID-19 vaccination across Dravet Syndrome population....
News Specialist AreaA new publication on the efficacy of Fenfluramine was issued recently in Epilepsia, acknowledging how the registry RESIDRAS can serve as a useful tool...
News Specialist AreaWe would like to present to you our new Board of Directors and the new Executive Committee, following elections held at the beginning of May 2020....
Events News23 June 2020 will be the sixth Dravet Awareness Day. On this occasion, patient organisations from around the world will take different actions to raise awarenes...
Events NewsThe long awaited results of “Vaccination in Dravet Syndrome – a European survey” are finally out! Most probably, the fact that only 55% of the patients included...
Events News Specialist AreaHappy to start 2020 with a supplement of Epilepsia dedicated to Dravet Syndrome - Volume 60, Issue S3. Published under the title "Dravet Syndrome and other sodi...
Events News Specialist AreaThe fifth Dravet Awareness Day will be held on June 23rd. On this day, patient organisations around the world call attention to the rare “Dravet Syndrome”. Peop...
Events NewsDravet Croatia is organising its first conference about Dravet Syndrome. The event will cover, in plenary sessions and round tables, several major topics such a...
Events NewsBookings are now open for the upcoming DSUK conference in November, and you are welcome to join us on either Professional Day or Parent/Carer Day. Please check ...
Activity EventsWe are happy to announce that Dravet Romania is the latest European association to agree to join Platform Residras. Dravet Syndrome European Federation, Stricht...
Activity EventsA new research which has just been funded by the Italian charity Gruppo Famiglie Dravet Onlus, supported by five other European associations dedicated to Dravet...
Activity Events Specialist AreaDid you know there are 14 developing therapies to treat Dravet Syndrome? And that several of the therapies do not seek only to control epileptic seizures but to...
Activity Events Specialist AreaOn 18th June the European Commission appointed members representing patients’ organisation to the Committee for Orphan Medicinal Products (COMP) of the European...
Activity Events Specialist AreaWe are very happy to announce that the Deutsche Forschungsgemeinschaft (DFG – German Research Foundation), a German research funding organization financed by th...
Activity Events Specialist AreaSudden Unexpected Death in Epilepsy – SUDEP – is a rare event and refers to a death in a person with epilepsy in which there is no other clear cause of death (s...
Activity EventsFor all its projects, Dravet Syndrome European Foundation was awarded by Eurordis the title “Patient Organisation 2017”. DSEF became member of Eurordis in 2015....
Activity Events Specialist AreaThe EpiCARE network would develop and deliver highly-specialized diagnostics and care to improve interventions and outcome in individuals with rare and complex ...
Activity Events Specialist Area